Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M L Casan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Blood|January 3, 2024
Degraders upgraded: the rise of PROTACs in hematological malignanciesJoshua M L Casan, John F Seymour
Blood Advances|May 14, 2026
On the RAdR in relapsed T-cell lymphomaJoshua M L Casan, Carrie Van Der Weyden
Expert Review of Clinical Immunology|July 14, 2025
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndromeFriyana K Bhabha, Carrie Van Der Weyden, Joshua M L Casan, et al.
Journal of Personalized Medicine|November 26, 2025
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision TherapeuticsJoshua M L Casan, Xiao Jing Ong, Carrie van der Weyden, et al.
Nature Communications|July 14, 2021
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch toleranceMohamed Fareh, Wei Zhao, Wenxin Hu, et al.
Nature Structural & Molecular Biology|July 1, 2024
Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencingWenxin Hu, Amit Kumar, Syed Faraz Ahmed, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Blood|January 3, 2024
Degraders upgraded: the rise of PROTACs in hematological malignanciesJoshua M L Casan, John F Seymour
Blood Advances|May 14, 2026
On the RAdR in relapsed T-cell lymphomaJoshua M L Casan, Carrie Van Der Weyden
Expert Review of Clinical Immunology|July 14, 2025
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndromeFriyana K Bhabha, Carrie Van Der Weyden, Joshua M L Casan, et al.
Journal of Personalized Medicine|November 26, 2025
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision TherapeuticsJoshua M L Casan, Xiao Jing Ong, Carrie van der Weyden, et al.
Nature Communications|July 14, 2021
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch toleranceMohamed Fareh, Wei Zhao, Wenxin Hu, et al.
Nature Structural & Molecular Biology|July 1, 2024
Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencingWenxin Hu, Amit Kumar, Syed Faraz Ahmed, et al.
Pageof 1